Clinical trial

PK/PD Study of U-500 Regular Insulin

NCT02148250

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2015-07-01

PhasePHASE2

Study timeline

Study start (unknown)2015-07-01Date precision: month

Registry last updated2020-02-26

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 2 Diabetesverified · MONDO: type 2 diabetes mellitus

Insulin Resistanceunresolved

High Insulin Requirementsunresolved

Interventions

U-500 insulin, 100 syringe unitsDRUG

U-500 insulin, 200 syringe unitsDRUG

Sponsors & collaborators

University of Minnesotalead sponsor

Eli Lilly and Companycollaborator

Mapped research locations

MinneapolisMinnesota, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02148250 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.